EPGL. Nice chart.

New biomedical device company launching FDA 510k-cleared device worldwide in 1st quarter of 2013.

EPGL will make a major announcement of interest for shareholders on January 25, 2013.

The January 25, 2013 announcement will be made in the morning via Twitter and National PR release simultaneously to be followed with a live conference call conducted by EPGL Team members.

The announcement will be of interest to EPGL shareholders and the investment community in three major areas:

1. Details on the progress of the upcoming MPDD release, order projections, manufacturing and distribution details.

2. A sneak peak at 6 new devices in development stages in addition to MPDD and MPTT, including major areas of diagnosis and treatment which the new devices will address in the healthcare market information on Governmental approval process, including FDA 510k applications and US Patent Applications in progress.

3. New EPGL Team members announcements and general overview of the Company business strategy moving into 2013.

http://www.epglmed.com